Inovio Pharmaceuticals, Inc.
A maker of DNA-based vaccines and medicines that teach the body's own cells to fight disease. The company designs synthetic DNA instructions and delivers them with its hand-held CELLECTRA device, whose brief electrical pulses open tiny pores in cells to target cancers and HPV-related conditions. Founded in 1983 as Biotechnologies & Experimental Research, it later operated as Genetronics and took its current name after acquiring the Norwegian gene-delivery firm Inovio in 2005.
Sold 17.21M
Granted 2.41M · Bought 820.4K · Sold 3.04M
Granted 30.8K · Bought 752.8K
Granted 1.22M
Granted 144.4K · Bought 41.5K · Sold 21.8K
Granted 682.3K · Sold 133.5K
Granted 272.7K · Bought 20.0K
Granted 123.0K · Bought 60.0K
Granted 362.6K · Sold 146.9K
Granted 38.9K · Bought 123.0K
Granted 500.7K · Bought 24.5K · Sold 79.0K
Granted 758.0K · Bought 90.1K · Sold 218.8K
Granted 83.3K
Granted 22.7K
Granted 122.4K · Bought 26.0K · Sold 36.5K
Granted 78.5K
Granted 70.9K
Granted 62.9K
Granted 48.3K
Granted 70.3K · Sold 13.3K
Granted 5.0K
Granted 4.1K
Granted 47.5K · Sold 47.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Marxe Austin W & Greenhouse David M10% owner · 65 transactions | — | 20.65Mas of Dec 2012 | — | — | 17.21M |
| Kim Jong JosephChief Executive Officer, Director · 100 transactions | — | 2.35Mas of Mar 2022 | 2.41M | 820.4K | 3.04M |
| Collins MortonDirector · 33 transactions | — | 365.2Kas of May 2019 | 30.8K | 752.8K | — |
| Rassas KevinSr. VP Business Development · 6 transactions | — | 215.9Kas of Nov 2009 | 1.22M | — | — |
| Sardesai NiranjanChief Operating Officer · 22 transactions | — | 123.5Kas of Mar 2018 | 144.4K | 41.5K | 21.8K |
| Shea Jacqueline ElizabethChief Executive Officer, Director · 55 transactions | — | 111.0K | 682.3K | — | 133.5K |
| Dhillon Avtar SDirector · 9 transactions | — | 106.0Kas of Dec 2018 | 272.7K | 20.0K | — |
| Bagarazzi MarkChief Medical Officer · 15 transactions | — | 100.7Kas of Mar 2019 | 123.0K | 60.0K | — |
| Weiner David B.Director · 58 transactions | — | 87.6K | 362.6K | — | 146.9K |
| Cabrera AngelDirector · 8 transactions | — | 75.6Kas of May 2020 | 38.9K | 123.0K | — |
| Humeau LaurentChief Scientific Officer · 57 transactions | — | 49.0K | 500.7K | 24.5K | 79.0K |
| Kies PeterCFO · 85 transactions | — | 47.9K | 758.0K | 90.1K | 218.8K |
| Sumner Michael JohnChief Medical Officer · 16 transactions | — | 42.0K | 83.3K | — | — |
| Mahmoud AdelDirector · 3 transactions | — | 22.7Kas of May 2018 | 22.7K | — | — |
| Benito Simon XDirector · 33 transactions | — | 12.2Kas of May 2025 | 122.4K | 26.0K | 36.5K |
| Yarno Wendy LDirector · 10 transactions | — | 10.5Kas of May 2025 | 78.5K | — | — |
| Miller Ann CalbyDirector · 9 transactions | — | 9.9Kas of May 2025 | 70.9K | — | — |
| Shepard JayDirector · 8 transactions | — | 9.2Kas of May 2025 | 62.9K | — | — |
| Dansey Roger DDirector · 6 transactions | — | 8.9Kas of May 2025 | 48.3K | — | — |
| Zoth Lota S.Director · 14 transactions | — | 8.7Kas of May 2025 | 70.3K | — | 13.3K |
| Wysenski NancyDirector · 1 transaction | — | 5.0Kas of May 2016 | 5.0K | — | — |
| Bickerstaff GeorgeDirector · 1 transaction | — | 4.1Kas of Mar 2018 | 4.1K | — | — |
| Goodenew Robert SV.P. Corporate Development · 9 transactions | — | — | 47.5K | — | 47.5K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -18.99M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.